| | | | Index Performance | | Index | Sensex | Nifty | | Open | 14,478.75 | 4,259.40 | | High | 14,560.48 | 4,296.15 | | Low | 14,478.75 | 4,250.10 | | Today's Cls | 14,501.08 | 4,285.70 | | Prev Cls | 14,487.72 | 4,259.40 | | Change | 13.36 | 26.3 | | % Change | 0.09 | 0.62 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Novartis | 398.30 | 14.42 | | Titan | 1,279.30 | 8.78 | | GMDC | 837.35 | 7.48 | | GMR Infra | 691.95 | 6.49 | | Reliance Petroleum | 106.75 | 5.85 | | Losers | | GE Shipping | 335.90 | -3.45 | | Canara Bank | 255.75 | -3.07 | | UTI Bank | 599.90 | -2.70 | | FDC | 34.35 | -2.55 | | Nicholas Piramal | 287.60 | -2.54 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,492 | 571 | | Declines | 1,117 | 484 | | Unchanged | 84 | 46 | | Volume(Nos) | 24.73cr | 34.06cr | | | | | | Market Commentary | | | Sensex posts modest gains | | After staying firm for the better part of the session the Sensex slipped on profit booking in front-line stocks and closed marginally above its previous close. | | The market returned to stability in the afternoon and gradually picked up momentum on healthy buying in consumer durables, capital goods and oil stocks but | | | | slipped into the red on profit booking towards the close. The Sensex opened on a cautious note at 14479, down nine points, tracing weak Asian markets. The market remained choppy thereafter but with a positive bias. It moved gradually up on sustained buying in front-line stocks to touch the day's high of 14560. However, a strong bout of selling thereafter saw the market enter into the red towards the close but buying at lower levels helped the Sensex to pare some of the losses and enter into positive territory again. The Sensex finally closed at 14501, up 13 points, while the Nifty ended the session at 4286, up 26 points.
The broader market, however, continued to remain in the green. Of the 2,693 stocks traded on the BSE, 1,492 stocks advanced, 1,117 stocks declined and 84 stocks ended unchanged. Most of the sectoral indices ended in the green. The BSE CD was the biggest gainer and moved up by 2.71% at 4164 followed by the BSE CG index (up 1.01% at 11950) and the BSE PSU index (up 0.75% at 6789). However, the BSE Bankex index dropped 0.36% at 7802 and the BSE IT index was down 0.25% at 4800. | | | Movers & Shakers | - Natco Pharma surged on receiving USFDA approval for its Ondansetron Hydrochloride tablets in multiple strengths.
- Aurobindo Pharma closed in the red despite receiving a tentative approval from the USFDA for Quinapril Hydrochloride and Hydrochlorothiazide tablets.
- Dollex Industries jumped on bagging an order of $5 million for IMFL from Africa.
- Pratibha Industries moved up on securing a contract from Jabalpur Municipal Corporation for a water supply scheme worth Rs26.44 crore.
| | | |
Among the laggards Ranbaxy was down 2.36% at Rs348, HDFC declined by 1.27% at Rs1,880, Wipro shed 1.25% at Rs509 and ACC dropped 1.17% at Rs846. However, select heavyweights attracted buying support. ONGC surged 2.11% at Rs936, Bharti Airtel rose 2.01% at Rs850, Grasim jumped 1.44% at Rs2,496, BHEL added 1.40% at Rs1,471 and Tata Motors moved up by 1.07% at Rs684.
Consumer durable stocks, however, were in the limelight. Titan Industries surged 8.78% at Rs1,279, Timex Watches jumped 5% at Rs26, Samtel Color soared 4.68% at Rs16 and Goldiam International gained 3.13% at Rs97. Llyod Electric, Shrenuj & Company, Nilkamal were up over 1% each.
Over 1.43 crore Reliance Petroleum shares changed hands on the BSE followed by IFCI (1.03 crore shares), GV Films (92.60 lakh shares), IKF Technologies (83.25 lakh shares) and Hindalco (51.65 lakh shares).
Time Technologies topped the value list with a turnover of Rs200 crore on the BSE followed by Indiabulls (Rs189 crore), Indiabulls Real Estate(Rs123 crore), Reliance Petroleum (Rs119 crore) and GMR Infrastructure (Rs103 crore).
| | | | | | | | European Indices at 16:20 IST on 26-06-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 6568.60 | -19.80 | -0.30 | | CAC 40 Index | 5961.33 | -41.52 | -0.69 | | DAX Index | 7858.36 | -72.25 | -0.91 | | | | | | | | | | | Asian Indices at close on 26-06-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 18066.11 | -21.37 | -0.12 | | Hang Seng | 21803.57 | -18.78 | -0.09 | | Kospi Index | 1749.55 | -8.18 | -0.47 | | Straits Times | 3525.10 | -55.23 | -1.54 | | Jakarta Composite Index | 2153.54 | 1.34 | 0.06 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
No comments:
Post a Comment